MassDevice

Study highlights effectiveness of Medtronic adaptive DBS in Parkinson’s

Medtronic (NYSE: MDT) today announced study results backing its adaptive DBS algorithm for personalized therapy in ...
MobiHealthNews

Medtronic's deep brain stimulation programmer and app get the FDA nod

Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application. "This marks a new era of innovation from the ...
Medscape

How Adaptive DBS Is Transforming Parkinson’s Treatment Across the Globe

Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy ...
WDAF-TV

Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever GALWAY, Ireland, Feb. 24, 2025 ...
Nasdaq

Medtronic Launches New Activa™ Patient Programmer for DBS Therapy

DUBLIN and SAN JOSE, Calif., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the U.S. launch of its advanced Patient Programmer technology for Deep Brain Stimulation (DBS) ...
Benzinga.com

FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients

Medtronic's BrainSense aDBS personalizes Parkinson's therapy in real-time, minimizing manual adjustments for better symptom control. BrainSense Electrode Identifier speeds up initial DBS programming ...
Business Insider

Medtronic Receives CE Mark Approval for SenSight™ Directional Lead System for DBS Therapy

This First-of-its-Kind Directional Lead Combines the Benefits of Directionality with the Power of Sensing DUBLIN, March 22, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical ...
St. Louis American

Navy Veteran and Parkinson’s patient credits Medtronic DBS therapy for restoring independence

Medtronic Percept™ DBS therapy is the only sensing-enabled † DBS system available, allowing a physician to use data from a patient’s brain activity to personalize their treatment. Andy says Medtronic ...
VentureBeat

Samsung and Medtronic use app for Parkinson’s disease patient therapy

At Samsung Developer Conference 2019 today, Medtronic and Samsung showed off a Galaxy smartphone app, Patient Programmer, that allows patients to manage their own therapy for Parkinson’s disease.
Seeking Alpha

Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever There is no cure for debilitating ...
Nasdaq

Medtronic Receives CE Mark Approval for SenSight™ Directional Lead System for DBS Therapy

This First-of-its-Kind Directional Lead Combines the Benefits of Directionality with the Power of Sensing "This is the only directional lead with built-in sensing capabilities," said Jens Volkmann, ...